Bitcoin

The study adds to the growing body of evidence on long COVID's biological basis, potentially shaping public health policy and healthcare costs. For crypto, this is a macro-neutral event, but it reinforces the narrative of ongoing pandemic-related uncertainties that have historically driven volatility in risk assets. The market's current focus remains on inflation, Fed policy, and BTC's technical levels.

A study published in Nature reports that chronic reactivation of distinct herpesviruses and anelloviruses occurs during acute and long COVID-19, tracking with disease severity and outcomes.

Nature Study Links Chronic Viral Reactivation to Long COVID Severity

Long COVID Study Is Actually Bullish for Bitcoin – Here's Why the Market Has It Backwards

In a macro environment where risk assets are under pressure from inflation and rate concerns, positive health developments that boost workforce productivity and economic output are a subtle tailwind. However, the crypto market is more sensitive to liquidity and regulatory signals than to medical breakthroughs, so the effect is indirect and delayed.

Two drugs show promise in reducing the risk of long COVID based on rigorous trials.